NEW YORK (GenomeWeb) – Interleukin Genetics today reported that its first quarter revenues fell 17 percent year over year on lower genetic testing service revenue.

The Waltham, Massachusetts-based genetic testing firm reported total revenues of $403,212 for the three months ended March 31 compared to $487,566 for the first quarter of 2014. Its genetic testing service revenue declined to $347,900 from $420,333 year over year, which the firm attributed to a decrease in genetic test kits returned for processing from a promotional product bundle program.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.